NEWS 12 FEED & ADDITIVE MAGAZINE September 2024 Huvepharma Inc., aiming to strengthen its commitment to production animal health, entered into a sales and marketing agreement with ADM, one of the global leaders in innovative solutions from nature, to widen its ruminant nutrition portfolio. Through this partnership, three ADM feed additives will be made available immediately to the ruminant product line of Huvepharma's growing list of livestock solutions. "This agreement with Huvepharma will expand producers' access to ADM's science-based feed additives that have demonstrated effects on production efficiencies," said Simon Walley, President-North America, ADM Animal Nutrition. "Precise and responsible animal feeding are the core of our global animal nutrition business. We are dedicated to optimizing nutrition and supporting animal health while mitigating environmental impacts. ADM continually investigates new technologies to serve global nutritional needs, including nutrition solutions to mitigate stressors and improve animal performance." ADM's feed additive solutions are supported by research exploring their bioactive and physiological activity and impacts on animal performance. Included in this new agreement are the following solutions: “Forming this partnership with ADM is another demonstration of Huvepharma’s commitment to supplying the industry with excellent nutritional solutions that meet the challenges unique to animal agriculture,” explained Glen Wilkinson, President of Huvepharma Inc. Read more>> Huvepharma partners with ADM for ruminant nutrition One of the global leaders in yeast manufacturing, Angel Yeast unveiled an initiative that unites universities and enterprises to form an innovative consortium dedicated to advancing synthetic biology technology. This initiative also accelerates the construction of the Xiaoting Synthetic Biology Industrial Park in Yichang, Hubei Province, China. Angel Yeast explains its goal as to establish an integrated industry chain, starting with yeast production and extending through fermentation of raw materials, bio-manufacturing, and product application. By 2035, this initiative aims to develop a 50-billion-yuan (USD 6.89 billion) industry cluster. In the era of rapid technology development, synthetic biology has been coined "the third biological science revolution". It makes each cell a "super factory" that can continuously produce specific substances after targeted modification, to be widely used in the manufacturing of food, medicine, biochemicals, new materials and more. At present, yeast is one of the most applicable microbial cell factory platforms with high editability and controllability. As one of the global leaders in the field of yeast R&D and production, Angel Yeast points out it has been laying out the industry roadmap for synthetic biology to accelerate its development. With this in mind, the Xiaoting Synthetic Biology Industrial Park was unveiled in 2023 and the consortium was founded in May 2024. Read more>> Angel Yeast brings together consortium for synthetic biology development
RkJQdWJsaXNoZXIy MTUxNjkxNQ==